The recent release of the FDA’s proposed Unique Device Identification (UDI) rule moves the healthcare industry closer to adopting standards for product identification. This rule is designed to allow manufacturers, distributors and healthcare facilities to more effectively manage medical device recalls. To help explain the impact of UDI on the healthcare supply chain and patient care, Infor Healthcare invited Dr. Natalia Wilson, Co-Director of the Health Sector Supply Chain Research Consortium at Arizona State University to share her perspectives on the value of UDI across healthcare. View the webinar recording to learn about the benefits of adopting standards in your organization and optimizing the value of UDI.
More about the speaker.
Natalia Wilson, MD, MPH is co-director of the Health Sector Supply Chain Research Consortium at Arizona State University (HSRC-ASU). She is trained in internal medicine.
Dr. Wilson’s clinical experience has included partnership in a community-based private internal medicine practice where she focused on preventive medicine and women’s health. Dr. Wilson conducts research, writes, and speaks on topics related to the healthcare supply chain. Her research interests include the changing relationships between physicians-hospitals-suppliers-patients, physician engagement in the healthcare supply chain, trust and collaboration, unique device identification (UDI), comparative effectiveness research, and healthcare reform.
Recent publications include Aligning Stakeholder Incentives in Orthopaedics, Hip and Knee Implants: Current Trends and Policy Considerations, and “Engaging Physicians in Collaborative Supply Cost Management,” included in the book Getting It Done: Experienced HealthCare Leaders Reveal Field-Tested Strategies for Clinical and Financial Success.Register now to view the webinar recording.
Please complete the form below to access the recorded webcast.